At ARVO 2025, in Salt Lake City, Utah, David Almeida, MD, MBA, PhD, talked about 12-month results from the PAVIA phase 2 ...

Kapil Mishra, MD, discusses his presentation title "Radiation Retinopathy: Future Strategies" given at the 2025 Retina World ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Viridian Therapeutics reveals promising long-term results for veligrotug in treating thyroid eye disease, highlighting its ...

At ARVO 2025, in Salt Lake City, Utah, Danielle Gauthuer talked about her poster on autosomal dominant Alzheimer's disease in relation to optic nerve head drusen.

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

A recent study reveals a significant rise in childhood astigmatism linked to the COVID-19 pandemic, independent of myopia.

Financing will fund phase 1b trials evaluating its lead candidate, THN391, for the treatment of Alzheimer’s Disease and ...

Ashvattha Therapeutics reveals promising phase 2 results for migaldendranib, showcasing significant improvements in retinal ...

At ARVO 2025, in Salt Lake City, Utah, Roger Goldberg, MD, MBA, talked about his presentation on the effect of AREDS vitamins in geographic atrophy.

Shifting from a regulatory role to driving innovation directly, Eydelman discusses how the Collaborative Community on ...

A machine learning model incorporating treated astigmatism and nuanced inputs is advancing the precision and personalization ...